RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Syneos Health Stock

Syneos Health Revenue 2024

Syneos Health Revenue

5.37 B USD

Ticker

SYNH

ISIN

US87166B1026

WKN

A2JBKW

In 2024, Syneos Health's sales reached 5.37 B USD, a 1.8% difference from the 5.28 B USD sales recorded in the previous year.

The Syneos Health Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2027e--
2026e--
2025e--
2024e--
2023e--
2022--
2021--
2020--
2019--
2018--
2017--
2016--
2015--
2014--
2013--
2012--
2011--

Syneos Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Syneos Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Syneos Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Syneos Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Syneos Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Syneos Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Syneos Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Syneos Health’s growth potential.

Syneos Health Revenue, EBIT and net profit per share

DateSyneos Health RevenueSyneos Health EBITSyneos Health Net Income
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
2023e0 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined

Syneos Health stock margins

The Syneos Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Syneos Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Syneos Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Syneos Health's sales revenue. A higher gross margin percentage indicates that the Syneos Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Syneos Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Syneos Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Syneos Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Syneos Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Syneos Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Syneos Health Margin History

Syneos Health Gross marginSyneos Health Profit marginSyneos Health EBIT marginSyneos Health Profit margin
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
2023e0 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %

Syneos Health Aktienanalyse

What does Syneos Health do?

Syneos Health is a US-based pharmaceutical and biotech service company. They specialize in providing integrated solutions for clinical research, commercial services, and data analysis. The company was founded in 2017 through the merger of two leading service companies, INC Research and inVentiv Health. Today, Syneos Health is one of the largest providers of clinical and commercial services in the pharmaceutical and biotech industry. They support their customers in the development and marketing of medications, diagnostics, and medical devices by offering a wide range of services including planning and conducting clinical trials, data analysis and management, and product marketing. Syneos Health operates in four business areas: clinical solutions, commercial solutions, consulting services, and clinical data analysis. Their primary focus is on delivering customer-centric services that cover various aspects of the pharmaceutical and biotech industry value chain. Within their clinical and medical segment, they conduct clinical trials and provide supporting services. They have expertise in clinical research and have successfully executed numerous studies. Syneos Health also offers consulting services in the areas of data management systems and clinical trials. In the commercial segment, they assist customers with marketing, sales promotion, and channel management to ensure the successful launch and sales of products. They provide training for sales staff, market research and analysis, and continuous support from sales and marketing experts. Their consulting services encompass strategy consulting, market research, branding, and communication. They also assist with the development, implementation, and validation of clinical trials, literature research, and regulatory support. Syneos Health's clinical data analysis involves analyzing large data sets to gain insights into the healthcare industry. They utilize cutting-edge technologies such as Big Data Analytics and Machine Learning to provide customers with valuable insights that aid in decision-making. In addition to clinical trials and consulting, Syneos Health offers modern technologies for the development and marketing of medications. This includes Virtual Reality solutions, personalized patient programs for chronic disease treatment, and digital platforms for data collection, analysis, and management. Syneos Health serves globally operating pharmaceutical and biotech companies that rely on their services to develop and market innovative medications and treatment methods. Customers value Syneos Health's expertise and trust that the company will help them successfully bring their products to market. Overall, Syneos Health is a leading company in the pharmaceutical and biotech industry. Their integrated services enable customers to work faster and more effectively. By combining expertise in clinical research, commercial solutions, consulting services, and clinical data analysis, Syneos Health offers innovative and successful solutions to its customers. Syneos Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Syneos Health's Sales Figures

The sales figures of Syneos Health originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Syneos Health’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Syneos Health's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Syneos Health’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Syneos Health stock

How much revenue did Syneos Health generate this year?

Syneos Health has achieved a revenue of 5.37 B USD this year.

How much was the turnover of the company Syneos Health compared to the previous year?

The revenue of Syneos Health has increased by 1.8% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Syneos Health?

The revenue of Syneos Health is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Syneos Health measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Syneos Health so important for investors?

The revenue of Syneos Health is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Syneos Health pay?

Over the past 12 months, Syneos Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Syneos Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Syneos Health?

The current dividend yield of Syneos Health is .

When does Syneos Health pay dividends?

Syneos Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Syneos Health?

Syneos Health paid dividends every year for the past 0 years.

What is the dividend of Syneos Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Syneos Health located?

Syneos Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Syneos Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Syneos Health from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Syneos Health pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Syneos Health in the year 2023?

In the year 2023, Syneos Health distributed 0 USD as dividends.

In which currency does Syneos Health pay out the dividend?

The dividends of Syneos Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Syneos Health

Our stock analysis for Syneos Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Syneos Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.